Weil G J, Lammie P J, Richards F O, Eberhard M L
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
J Infect Dis. 1991 Oct;164(4):814-6. doi: 10.1093/infdis/164.4.814.
This study assessed changes in circulating parasite antigen levels after diethylcarbamazine (DEC) and ivermectin treatment of bancroftian filariasis to determine effects of these drugs on adult Wuchereria bancrofti in vivo. Thirty adult Haitians with microfilaremia were treated with 1 mg of ivermectin to reduce counts of microfilariae. Later, subjects were treated with either one or two 200 micrograms/kg doses of ivermectin or with 12 daily 6 mg/kg doses of DEC. Macrofilaricidal activity of these drugs was indirectly monitored by measuring circulating W. bancrofti antigen by EIA. Antigen levels fell by 75% after DEC and by 34% after ivermectin. These results suggest that low-dose ivermectin treatment followed by a standard course of DEC is a more effective macrofilaricidal regimen for W. bancrofti than either of the multidose ivermectin regimens used in this study.
本研究评估了乙胺嗪(DEC)和伊维菌素治疗班氏丝虫病后循环中寄生虫抗原水平的变化,以确定这些药物对体内成年班氏吴策线虫的影响。30名患有微丝蚴血症的成年海地人接受了1毫克伊维菌素治疗以减少微丝蚴数量。之后,受试者分别接受1或2剂200微克/千克剂量的伊维菌素治疗,或接受12天每日6毫克/千克剂量的DEC治疗。通过酶免疫分析(EIA)测量循环中的班氏吴策线虫抗原,间接监测这些药物的杀成虫活性。DEC治疗后抗原水平下降了75%,伊维菌素治疗后下降了34%。这些结果表明,低剂量伊维菌素治疗后再进行标准疗程的DEC治疗,对于班氏吴策线虫而言,是一种比本研究中使用的任何一种多剂量伊维菌素治疗方案更有效的杀成虫方案。